HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

YZYBIO-B

3.300

0.000

Volume:- -

Turnover:- -

Market Cap:640.20M

PE:-6.46

High:3.300

Open:3.300

Low:3.300

Close:3.300

52wk High:8.400

52wk Low:3.300

Shares:194.00M

HK Float Shares:179.48M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.511

ROE:-704.81%

ROA:-6.51%

PB:-9.36

PE(LYR):-6.46

PS:8.72

Loading ...

Overview Company News Filings

Wuhan YZY Biopharma Co Ltd - Nda for M701 Accepted by Nmpa for Treatment of Malignant Ascites

THOMSON REUTERS

YZYBIO-B Keeps Share Capital Steady in April; 1.25 Million H-Share Options Outstanding

Bulletin Express

YZY Biopharma’s M701 Clinical Data Earns Dual Slots at 2026 ASCO Annual Meeting

Bulletin Express

YZYBIO-B (02496): Two M 701 Research Findings Selected for Presentation at 2026 ASCO Annual Meeting

Wuhan YZY Biopharma says M701 Phase III malignant ascites data selected for ASCO oral presentation

YZYBIO releases 2025 ESG report: RMB 78.20 million R&D spend, 9% drop in per-capita carbon emissions

Bulletin Express

友芝友生物2025年收入下滑、研发投入减少并聚焦双特异抗体管线

Bulletin Express

Wuhan YZY Biopharma publishes 2025 annual report

YZYBIO-B Completes 68.01 Million-Share Full-Circulation Conversion, Elevating H-Share Float to 179.48 Million

Bulletin Express

YZYBIO-B Lists Additional 68.01 Million H Shares After Converting Domestic and Unlisted Foreign Stock, Enlarging HK-Traded Float by 61%

Bulletin Express

H-Share Conversion Finalized by YZYBIO-B (02496)

Wuhan YZY Biopharma completes conversion of 68 million unlisted shares into H shares

Wuhan YZY Biopharma (SEHK:2496) Loss Deepens In 1H 2025 Challenging Improving Loss Trend Narrative

Simply Wall St.

YZYBIO-B Reports Annual Performance: Net Loss Narrows 13.18% to 84.73 Million Yuan

Wuhan YZY Biopharma - FY Revenue RMB66.9 Mln

THOMSON REUTERS

Wuhan Yzy Biopharma FY2025 gross profit drops 87.38% to RMB11 million; revenue falls 37.99% to RMB67 million

Wuhan YZY Biopharma board to review and approve 2025 final results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/02496/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02496","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02496\",,,,,undefined,":{"symbol":"02496","market":"HK","secType":"STK","nameCN":"YZYBIO-B","latestPrice":3.3,"timestamp":1789002001116,"preClose":3.3,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":179479113,"shares":194000000,"eps":-0.5107812102749876,"marketStatus":"Closed","change":0,"latestTime":"09-10 09:00:01","open":3.3,"high":3.3,"low":3.3,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":3.205,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-0.19385480432515503,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1695571200000,"exchange":"SEHK","adjPreClose":3.3,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02496\",,,,,undefined,":{"symbol":"02496","floatShares":179479113,"roa":"-6.51%","roe":"-704.81%","lyrEps":-0.510781,"shares":194000000,"dividePrice":0,"high":3.3,"amplitude":0,"preClose":3.3,"low":3.3,"week52Low":3.3,"pbRate":"-9.36","psRate":"8.72","week52High":8.4,"institutionHeld":0,"latestPrice":3.3,"committee":1,"eps":-0.5107812102749876,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.19385480432515503,"open":3.3,"prevYearClose":8.02,"prevWeekClose":3.3,"prevMonthClose":3.3,"prevQuarterClose":3.8,"fiveDayClose":3.3,"twentyDayClose":3.6,"sixtyDayClose":4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02496\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-27","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null},{"date":"2025-08-26","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-28","symbol":"02496","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"Post-Mkt","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-29","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724895000000,"name":null,"time":"","dateTimestamp":1724860800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02496\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02496\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02496\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02496","date":"2026-09-09","current":-17.02305,"percent":0.048077,"low":-18.565593,"twenty":-12.714572,"median":-8.249766,"eighty":-6.971794,"high":-3.741546,"avg":-9.446342,"sd":3.6633,"marketCap":639702360},"quantilePoints":[{"date":"2023-09-22","current":-15.261024,"twenty":-15.274233,"median":-15.26928,"eighty":-15.264326,"marketCap":3088019200},{"date":"2023-09-29","current":-15.292224,"twenty":-17.099581,"median":-15.293234,"eighty":-15.280473,"marketCap":3049418960},{"date":"2023-10-06","current":-15.493216,"twenty":-15.501023,"median":-15.292224,"eighty":-15.050323,"marketCap":3088019200},{"date":"2023-10-13","current":-15.380625,"twenty":-15.493216,"median":-15.348538,"eighty":-15.261024,"marketCap":3060999032},{"date":"2023-10-20","current":-10.535817,"twenty":-15.418704,"median":-15.300038,"eighty":-14.801616,"marketCap":2093571360},{"date":"2023-10-27","current":-9.759574,"twenty":-15.417248,"median":-15.292224,"eighty":-11.937608,"marketCap":1938492000},{"date":"2023-11-03","current":-9.733728,"twenty":-15.412338,"median":-15.155674,"eighty":-10.478048,"marketCap":1938492000},{"date":"2023-11-10","current":-8.275398,"twenty":-15.390041,"median":-14.508961,"eighty":-9.494912,"marketCap":1647718200},{"date":"2023-11-17","current":-8.703164,"twenty":-15.38145,"median":-11.695259,"eighty":-8.750672,"marketCap":1748519784},{"date":"2023-11-24","current":-8.421561,"twenty":-15.329285,"median":-10.573898,"eighty":-8.701771,"marketCap":1705872960},{"date":"2023-12-01","current":-7.919793,"twenty":-15.30332,"median":-10.003273,"eighty":-8.541365,"marketCap":1610886852},{"date":"2023-12-08","current":-8.497372,"twenty":-15.294595,"median":-9.516549,"eighty":-8.420238,"marketCap":1721380896},{"date":"2023-12-15","current":-8.258301,"twenty":-15.292426,"median":-9.276148,"eighty":-8.274722,"marketCap":1682611056},{"date":"2023-12-22","current":-8.349506,"twenty":-15.280473,"median":-8.776546,"eighty":-8.277258,"marketCap":1700057484},{"date":"2023-12-29","current":-8.428335,"twenty":-15.270931,"median":-8.740745,"eighty":-8.306436,"marketCap":1725257880},{"date":"2024-01-05","current":-8.249766,"twenty":-15.218884,"median":-8.699682,"eighty":-8.272694,"marketCap":1676795580},{"date":"2024-01-12","current":-8.302569,"twenty":-15.000582,"median":-8.571321,"eighty":-8.275563,"marketCap":1688426532},{"date":"2024-01-19","current":-8.113537,"twenty":-14.743085,"median":-8.513713,"eighty":-8.272694,"marketCap":1647718200},{"date":"2024-01-26","current":-7.982332,"twenty":-14.471602,"median":-8.481448,"eighty":-8.258393,"marketCap":1614763836},{"date":"2024-02-02","current":-7.992522,"twenty":-13.915342,"median":-8.424948,"eighty":-8.196137,"marketCap":1614763836},{"date":"2024-02-09","current":-8.02019,"twenty":-12.050937,"median":-8.406699,"eighty":-8.080173,"marketCap":1628333280},{"date":"2024-02-16","current":-8.343013,"twenty":-11.339581,"median":-8.370574,"eighty":-8.105196,"marketCap":1694242008},{"date":"2024-02-23","current":-8.30086,"twenty":-10.803844,"median":-8.369483,"eighty":-8.124586,"marketCap":1676795580},{"date":"2024-03-01","current":-8.247733,"twenty":-10.604956,"median":-8.362825,"eighty":-8.153154,"marketCap":1667103120},{"date":"2024-03-08","current":-8.186551,"twenty":-10.543433,"median":-8.343013,"eighty":-8.173812,"marketCap":1655472168},{"date":"2024-03-15","current":-8.155425,"twenty":-10.30474,"median":-8.311389,"eighty":-8.173276,"marketCap":1647718200},{"date":"2024-03-22","current":-7.39462,"twenty":-9.857053,"median":-8.302569,"eighty":-8.105196,"marketCap":1492638840},{"date":"2024-03-28","current":-7.61103,"twenty":-9.744066,"median":-8.301568,"eighty":-8.043049,"marketCap":1531408680},{"date":"2024-04-05","current":-7.288366,"twenty":-9.690292,"median":-8.300787,"eighty":-8.021295,"marketCap":1512023760},{"date":"2024-04-12","current":-6.976051,"twenty":-9.494912,"median":-8.295352,"eighty":-7.983468,"marketCap":1448053524},{"date":"2024-04-19","current":-6.963318,"twenty":-9.388856,"median":-8.276973,"eighty":-7.977458,"marketCap":1444176540},{"date":"2024-04-26","current":-6.971914,"twenty":-9.296949,"median":-8.272018,"eighty":-7.930221,"marketCap":1444176540},{"date":"2024-05-03","current":-6.976736,"twenty":-9.241479,"median":-8.264756,"eighty":-7.6347,"marketCap":1444176540},{"date":"2024-05-10","current":-6.960212,"twenty":-8.933122,"median":-8.256463,"eighty":-7.598809,"marketCap":1444176540},{"date":"2024-05-17","current":-6.970443,"twenty":-8.807861,"median":-8.251559,"eighty":-7.39462,"marketCap":1444176540},{"date":"2024-05-24","current":-7.095514,"twenty":-8.76114,"median":-8.247733,"eighty":-7.267873,"marketCap":1444176540},{"date":"2024-05-31","current":-7.0883,"twenty":-8.730819,"median":-8.237322,"eighty":-7.171233,"marketCap":1444176540},{"date":"2024-06-07","current":-7.097101,"twenty":-8.707372,"median":-8.195562,"eighty":-7.097101,"marketCap":1444176540},{"date":"2024-06-14","current":-7.132215,"twenty":-8.698985,"median":-8.193432,"eighty":-7.097238,"marketCap":1449992016},{"date":"2024-06-21","current":-7.988022,"twenty":-8.625304,"median":-8.18531,"eighty":-7.098087,"marketCap":1620579312},{"date":"2024-06-28","current":-7.48471,"twenty":-8.574009,"median":-8.177364,"eighty":-7.098775,"marketCap":1517839236},{"date":"2024-07-05","current":-7.715801,"twenty":-8.562528,"median":-8.159606,"eighty":-7.101937,"marketCap":1564363044},{"date":"2024-07-12","current":-7.141207,"twenty":-8.536784,"median":-8.120442,"eighty":-7.107036,"marketCap":1449992016},{"date":"2024-07-19","current":-7.131527,"twenty":-8.514561,"median":-8.053748,"eighty":-7.107036,"marketCap":1448053524},{"date":"2024-07-26","current":-7.10513,"twenty":-8.504633,"median":-8.029564,"eighty":-7.105677,"marketCap":1448053524},{"date":"2024-08-02","current":-7.109273,"twenty":-8.491002,"median":-8.019114,"eighty":-7.105677,"marketCap":1448053524},{"date":"2024-08-09","current":-7.033842,"twenty":-8.475712,"median":-7.991974,"eighty":-7.097834,"marketCap":1442238048},{"date":"2024-08-16","current":-6.879903,"twenty":-8.451599,"median":-7.985142,"eighty":-7.095806,"marketCap":1411222176},{"date":"2024-08-23","current":-6.041633,"twenty":-8.425625,"median":-7.981406,"eighty":-7.090359,"marketCap":1244511864},{"date":"2024-08-30","current":-6.047183,"twenty":-8.418914,"median":-7.97694,"eighty":-7.085583,"marketCap":1219311468},{"date":"2024-09-06","current":-6.034663,"twenty":-8.411646,"median":-7.942728,"eighty":-7.024202,"marketCap":1217372976},{"date":"2024-09-13","current":-6.050501,"twenty":-8.400619,"median":-7.919793,"eighty":-6.989131,"marketCap":1217372976},{"date":"2024-09-20","current":-5.899508,"twenty":-8.390451,"median":-7.809695,"eighty":-6.977241,"marketCap":1194111072},{"date":"2024-09-27","current":-5.635763,"twenty":-8.383344,"median":-7.722148,"eighty":-6.974189,"marketCap":1147587264},{"date":"2024-10-04","current":-6.646499,"twenty":-8.371665,"median":-7.71452,"eighty":-6.971914,"marketCap":1347251940},{"date":"2024-10-10","current":-6.670566,"twenty":-8.369919,"median":-7.665604,"eighty":-6.970443,"marketCap":1343374956},{"date":"2024-10-18","current":-5.989499,"twenty":-8.366581,"median":-7.61103,"eighty":-6.964903,"marketCap":1199926548},{"date":"2024-10-25","current":-5.941495,"twenty":-8.363757,"median":-7.592567,"eighty":-6.963278,"marketCap":1190234088},{"date":"2024-11-01","current":-5.753759,"twenty":-8.362581,"median":-7.48471,"eighty":-6.932913,"marketCap":1153402740},{"date":"2024-11-08","current":-5.323409,"twenty":-8.352088,"median":-7.478194,"eighty":-6.706839,"marketCap":1062293616},{"date":"2024-11-15","current":-4.810927,"twenty":-8.344312,"median":-7.39462,"eighty":-6.66868,"marketCap":949861080},{"date":"2024-11-22","current":-4.597104,"twenty":-8.320901,"median":-7.288282,"eighty":-6.614502,"marketCap":907214256},{"date":"2024-11-29","current":-4.511723,"twenty":-8.314189,"median":-7.193914,"eighty":-6.4628,"marketCap":889767828},{"date":"2024-12-06","current":-3.832688,"twenty":-8.309887,"median":-7.189483,"eighty":-6.054759,"marketCap":754073388},{"date":"2024-12-13","current":-3.741546,"twenty":-8.30727,"median":-7.147179,"eighty":-6.049837,"marketCap":734688468},{"date":"2024-12-20","current":-3.946605,"twenty":-8.303428,"median":-7.141207,"eighty":-6.034627,"marketCap":771519816},{"date":"2024-12-27","current":-6.936731,"twenty":-8.302316,"median":-7.140369,"eighty":-6.034555,"marketCap":1355005908},{"date":"2025-01-03","current":-7.8123,"twenty":-8.301863,"median":-7.141207,"eighty":-6.034663,"marketCap":1527531696},{"date":"2025-01-10","current":-7.782302,"twenty":-8.301426,"median":-7.145546,"eighty":-6.036057,"marketCap":1515900744},{"date":"2025-01-17","current":-7.348445,"twenty":-8.300831,"median":-7.189317,"eighty":-6.042743,"marketCap":1432545588},{"date":"2025-01-24","current":-7.302687,"twenty":-8.300293,"median":-7.192391,"eighty":-6.047847,"marketCap":1432545588},{"date":"2025-01-28","current":-7.264616,"twenty":-8.299451,"median":-7.229265,"eighty":-6.049174,"marketCap":1432545588},{"date":"2025-02-07","current":-7.236748,"twenty":-8.296655,"median":-7.256521,"eighty":-6.050501,"marketCap":1418976144},{"date":"2025-02-14","current":-6.936954,"twenty":-8.289567,"median":-7.234585,"eighty":-6.050566,"marketCap":1356944400},{"date":"2025-02-21","current":-6.209204,"twenty":-8.280918,"median":-7.193914,"eighty":-6.051176,"marketCap":1221249960},{"date":"2025-02-28","current":-5.735312,"twenty":-8.276823,"median":-7.189483,"eighty":-6.049174,"marketCap":1124325360},{"date":"2025-03-07","current":-4.382772,"twenty":-8.275728,"median":-7.147179,"eighty":-6.034591,"marketCap":862628940},{"date":"2025-03-14","current":-4.381178,"twenty":-8.27337,"median":-7.141207,"eighty":-6.005336,"marketCap":862628940},{"date":"2025-03-21","current":-4.382899,"twenty":-8.271865,"median":-7.139645,"eighty":-5.976203,"marketCap":862628940},{"date":"2025-03-28","current":-6.03007,"twenty":-8.267559,"median":-7.132215,"eighty":-5.958282,"marketCap":1184418612},{"date":"2025-04-03","current":-12.27285,"twenty":-8.275893,"median":-7.137062,"eighty":-5.959979,"marketCap":1279404720},{"date":"2025-04-11","current":-11.044555,"twenty":-8.297306,"median":-7.141207,"eighty":-5.971601,"marketCap":1143710280},{"date":"2025-04-17","current":-8.683774,"twenty":-8.301426,"median":-7.143912,"eighty":-5.986226,"marketCap":901398780},{"date":"2025-04-25","current":-8.769575,"twenty":-8.306866,"median":-7.147536,"eighty":-5.989499,"marketCap":911091240},{"date":"2025-05-02","current":-8.750975,"twenty":-8.320901,"median":-7.189649,"eighty":-5.997241,"marketCap":911091240},{"date":"2025-05-09","current":-8.320184,"twenty":-8.320865,"median":-7.193914,"eighty":-5.999307,"marketCap":872321400},{"date":"2025-05-16","current":-7.720916,"twenty":-8.320762,"median":-7.234585,"eighty":-6.005336,"marketCap":816105132},{"date":"2025-05-23","current":-7.734459,"twenty":-8.320415,"median":-7.256521,"eighty":-6.010152,"marketCap":819982116},{"date":"2025-05-30","current":-7.700604,"twenty":-8.317297,"median":-7.263991,"eighty":-6.01222,"marketCap":819982116},{"date":"2025-06-06","current":-7.681007,"twenty":-8.314485,"median":-7.286363,"eighty":-6.02333,"marketCap":819982116},{"date":"2025-06-13","current":-9.456792,"twenty":-8.320762,"median":-7.288884,"eighty":-6.03007,"marketCap":1009954332},{"date":"2025-06-20","current":-9.38443,"twenty":-8.354671,"median":-7.302687,"eighty":-6.032718,"marketCap":1000261872},{"date":"2025-06-27","current":-8.886685,"twenty":-8.370356,"median":-7.33658,"eighty":-6.034591,"marketCap":949861080},{"date":"2025-07-04","current":-8.886268,"twenty":-8.400619,"median":-7.39462,"eighty":-6.034663,"marketCap":949861080},{"date":"2025-07-11","current":-9.439834,"twenty":-8.450162,"median":-7.477671,"eighty":-6.037451,"marketCap":1008015840},{"date":"2025-07-18","current":-10.71898,"twenty":-8.504633,"median":-7.483524,"eighty":-6.043853,"marketCap":1143710280},{"date":"2025-07-25","current":-10.354306,"twenty":-8.575353,"median":-7.586326,"eighty":-6.04851,"marketCap":1108817424},{"date":"2025-08-01","current":-10.200109,"twenty":-8.700378,"median":-7.607601,"eighty":-6.050501,"marketCap":1085555520},{"date":"2025-08-08","current":-10.174658,"twenty":-8.73051,"median":-7.6347,"eighty":-6.050545,"marketCap":1085555520},{"date":"2025-08-15","current":-10.189926,"twenty":-8.755577,"median":-7.668855,"eighty":-6.050988,"marketCap":1085555520},{"date":"2025-08-22","current":-10.404516,"twenty":-8.778653,"median":-7.696508,"eighty":-6.053156,"marketCap":1104940440},{"date":"2025-08-29","current":-12.496435,"twenty":-8.886268,"median":-7.699076,"eighty":-6.05556,"marketCap":1066170600},{"date":"2025-09-05","current":-12.508831,"twenty":-8.917527,"median":-7.704882,"eighty":-6.055623,"marketCap":1066170600},{"date":"2025-09-12","current":-12.713379,"twenty":-9.283082,"median":-7.709288,"eighty":-6.056629,"marketCap":1085555520},{"date":"2025-09-19","current":-13.812899,"twenty":-9.372197,"median":-7.711903,"eighty":-6.091088,"marketCap":1178603136},{"date":"2025-09-26","current":-15.488824,"twenty":-9.421871,"median":-7.713577,"eighty":-6.168118,"marketCap":1318174560},{"date":"2025-10-03","current":-15.429223,"twenty":-9.439834,"median":-7.716349,"eighty":-6.209251,"marketCap":1316236068},{"date":"2025-10-10","current":-15.542765,"twenty":-9.48241,"median":-7.718907,"eighty":-6.209438,"marketCap":1323990036},{"date":"2025-10-17","current":-15.463777,"twenty":-9.516549,"median":-7.722508,"eighty":-6.564001,"marketCap":1316236068},{"date":"2025-10-24","current":-16.141138,"twenty":-9.993637,"median":-7.727404,"eighty":-6.587794,"marketCap":1374390828},{"date":"2025-10-31","current":-15.935241,"twenty":-10.174658,"median":-7.732892,"eighty":-6.604283,"marketCap":1358882892},{"date":"2025-11-07","current":-15.945201,"twenty":-10.180758,"median":-7.758053,"eighty":-6.609789,"marketCap":1358882892},{"date":"2025-11-14","current":-15.900146,"twenty":-10.200109,"median":-7.784219,"eighty":-6.614502,"marketCap":1358882892},{"date":"2025-11-21","current":-16.089098,"twenty":-10.29964,"median":-7.809695,"eighty":-6.640318,"marketCap":1374390828},{"date":"2025-11-28","current":-16.030869,"twenty":-10.386607,"median":-7.849274,"eighty":-6.646499,"marketCap":1374390828},{"date":"2025-12-05","current":-16.003355,"twenty":-10.404516,"median":-7.919793,"eighty":-6.658209,"marketCap":1374390828},{"date":"2025-12-12","current":-15.973808,"twenty":-10.577045,"median":-7.942728,"eighty":-6.66868,"marketCap":1374390828},{"date":"2025-12-19","current":-15.93625,"twenty":-10.714182,"median":-7.97694,"eighty":-6.670691,"marketCap":1374390828},{"date":"2025-12-24","current":-15.662693,"twenty":-10.90375,"median":-7.980005,"eighty":-6.674625,"marketCap":1355005908},{"date":"2026-01-02","current":-17.543083,"twenty":-11.095447,"median":-7.982691,"eighty":-6.684863,"marketCap":1523654712},{"date":"2026-01-09","current":-17.49951,"twenty":-11.336885,"median":-7.988022,"eighty":-6.703505,"marketCap":1523654712},{"date":"2026-01-16","current":-17.442827,"twenty":-12.451475,"median":-7.994219,"eighty":-6.740071,"marketCap":1523654712},{"date":"2026-01-23","current":-17.215232,"twenty":-12.506134,"median":-8.02019,"eighty":-6.870823,"marketCap":1502331300},{"date":"2026-01-30","current":-17.402236,"twenty":-12.672793,"median":-8.041443,"eighty":-6.879903,"marketCap":1525593204},{"date":"2026-02-06","current":-16.762691,"twenty":-13.116393,"median":-8.071832,"eighty":-6.881774,"marketCap":1473253920},{"date":"2026-02-13","current":-15.877471,"twenty":-13.767462,"median":-8.141386,"eighty":-6.889262,"marketCap":1403468208},{"date":"2026-02-20","current":-15.900374,"twenty":-14.02108,"median":-8.157515,"eighty":-6.889266,"marketCap":1403468208},{"date":"2026-02-27","current":-15.727885,"twenty":-14.413548,"median":-8.177364,"eighty":-6.902973,"marketCap":1403468208},{"date":"2026-03-06","current":-12.483086,"twenty":-14.626023,"median":-8.18531,"eighty":-6.913266,"marketCap":1104940440},{"date":"2026-03-13","current":-12.425855,"twenty":-14.413548,"median":-8.193432,"eighty":-6.925983,"marketCap":1104940440},{"date":"2026-03-20","current":-12.823206,"twenty":-14.349192,"median":-8.196999,"eighty":-6.935617,"marketCap":1135956312},{"date":"2026-03-27","current":-9.060567,"twenty":-14.332776,"median":-8.234591,"eighty":-6.936865,"marketCap":800597196},{"date":"2026-04-02","current":-8.304746,"twenty":-14.318035,"median":-8.244293,"eighty":-6.936954,"marketCap":800597196},{"date":"2026-04-10","current":-9.618041,"twenty":-14.311841,"median":-8.248749,"eighty":-6.936954,"marketCap":934353144},{"date":"2026-04-17","current":-9.614004,"twenty":-13.827239,"median":-8.252895,"eighty":-6.946166,"marketCap":934353144},{"date":"2026-04-24","current":-9.573569,"twenty":-13.812899,"median":-8.25853,"eighty":-6.950948,"marketCap":930476160},{"date":"2026-04-30","current":-9.168948,"twenty":-13.631151,"median":-8.268259,"eighty":-6.958359,"marketCap":891706320},{"date":"2026-05-08","current":-8.743175,"twenty":-13.502409,"median":-8.275398,"eighty":-6.962537,"marketCap":852936480},{"date":"2026-05-15","current":-10.226462,"twenty":-13.419752,"median":-8.281283,"eighty":-6.963278,"marketCap":1000261872},{"date":"2026-05-22","current":-10.249888,"twenty":-13.229802,"median":-8.295352,"eighty":-6.963681,"marketCap":1000261872},{"date":"2026-05-29","current":-8.511974,"twenty":-13.133287,"median":-8.300714,"eighty":-6.963936,"marketCap":833551560},{"date":"2026-06-05","current":-8.301973,"twenty":-12.941558,"median":-8.301752,"eighty":-6.964084,"marketCap":814166640},{"date":"2026-06-12","current":-8.307592,"twenty":-12.828822,"median":-8.301973,"eighty":-6.964705,"marketCap":814166640},{"date":"2026-06-18","current":-7.893055,"twenty":-12.823206,"median":-8.301937,"eighty":-6.9664,"marketCap":775396800},{"date":"2026-06-26","current":-7.5352,"twenty":-12.80087,"median":-8.300843,"eighty":-6.968747,"marketCap":736626960},{"date":"2026-07-03","current":-7.529568,"twenty":-12.757166,"median":-8.299661,"eighty":-6.969565,"marketCap":736626960},{"date":"2026-07-10","current":-7.53882,"twenty":-12.715765,"median":-8.28571,"eighty":-6.970443,"marketCap":736626960},{"date":"2026-07-17","current":-7.512086,"twenty":-12.713379,"median":-8.276973,"eighty":-6.970666,"marketCap":736626960},{"date":"2026-07-24","current":-7.292992,"twenty":-12.672793,"median":-8.272018,"eighty":-6.97157,"marketCap":715303548},{"date":"2026-07-31","current":-7.279164,"twenty":-12.510448,"median":-8.264756,"eighty":-6.971614,"marketCap":715303548},{"date":"2026-08-07","current":-7.186303,"twenty":-12.508831,"median":-8.256463,"eighty":-6.971914,"marketCap":707549580},{"date":"2026-08-14","current":-7.078899,"twenty":-12.508831,"median":-8.250223,"eighty":-6.973489,"marketCap":697857120},{"date":"2026-08-21","current":-7.06329,"twenty":-12.507767,"median":-8.246013,"eighty":-6.973742,"marketCap":697857120},{"date":"2026-08-28","current":-6.473214,"twenty":-12.50543,"median":-8.234591,"eighty":-6.971559,"marketCap":639702360},{"date":"2026-09-04","current":-17.049204,"twenty":-12.510448,"median":-8.246013,"eighty":-6.971614,"marketCap":639702360},{"date":"2026-09-09","current":-17.02196,"twenty":-12.714572,"median":-8.249766,"eighty":-6.971794,"marketCap":639702360}],"updateTime":1789042672287},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02496\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633111205","title":"Wuhan YZY Biopharma Co Ltd - Nda for M701 Accepted by Nmpa for Treatment of Malignant Ascites","url":"https://stock-news.laohu8.com/highlight/detail?id=2633111205","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633111205?lang=en_us&edition=fundamental","pubTime":"2026-05-07 17:33","pubTimestamp":1778146422,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K0CJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113166652","title":"YZYBIO-B Keeps Share Capital Steady in April; 1.25 Million H-Share Options Outstanding","url":"https://stock-news.laohu8.com/highlight/detail?id=1113166652","media":"Bulletin Express","labels":["SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113166652?lang=en_us&edition=fundamental","pubTime":"2026-05-06 17:04","pubTimestamp":1778058292,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. (YZYBIO-B) reported no change in either authorised or issued share capital for the month ended 30 April 2026, according to its latest monthly return filed with the Hong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152018804","title":"YZY Biopharma’s M701 Clinical Data Earns Dual Slots at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1152018804","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152018804?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:43","pubTimestamp":1776944612,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. (YZY Biopharma) disclosed that two pivotal studies for its core bispecific antibody candidate, M701, have been accepted for presentation at the 2026 American Society of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192949223","title":"YZYBIO-B (02496): Two M 701 Research Findings Selected for Presentation at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1192949223","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192949223?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:41","pubTimestamp":1776944466,"startTime":"0","endTime":"0","summary":"Yuzhiyou Biotech-B (02496) has announced that two clinical research findings related to its core innovative bispecific antibody product, M 701, have been selected for presentation at the 2026...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629835095","title":"Wuhan YZY Biopharma says M701 Phase III malignant ascites data selected for ASCO oral presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2629835095","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629835095?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:34","pubTimestamp":1776944061,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma reported two clinical study readouts for its bispecific antibody M701 were selected for presentation at 2026 ASCO Annual Meeting, with results to be presented in the future.Phase III study in malignant ascites was slated for an oral session on May 31, 2026, signaling elevated conference visibility for program.Phase II study in non-small cell lung cancer-related malignant pleural effusion was scheduled for poster presentation on May 30, 2026, supporting potential expansion across malignant serous cavity effusion indications.M701 targets EpCAM and CD3 to redirect T cells to kill tumor cells, positioning asset as a differentiated supportive-care option in settings with limited treatment choices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDLbFL5q3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166474674","title":"YZYBIO releases 2025 ESG report: RMB 78.20 million R&D spend, 9% drop in per-capita carbon emissions","url":"https://stock-news.laohu8.com/highlight/detail?id=1166474674","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166474674?lang=en_us&edition=fundamental","pubTime":"2026-04-16 23:09","pubTimestamp":1776352190,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. (YZYBIO, 02496) published its third Environmental, Social and Governance (ESG) report, covering the calendar year 2025 and prepared under the Hong Kong Stock Exchange...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141482640","title":"友芝友生物2025年收入下滑、研发投入减少并聚焦双特异抗体管线","url":"https://stock-news.laohu8.com/highlight/detail?id=1141482640","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141482640?lang=en_us&edition=fundamental","pubTime":"2026-04-16 23:09","pubTimestamp":1776352145,"startTime":"0","endTime":"0","summary":"武汉友芝友生物制药有限公司（以下简称“友芝友生物”，香港联交所股票代码：02496）于2025年继续深耕双特异抗体及相关创新药物研发，并披露了截至2025年12月31日的全年业绩和业务进展。根据公告，期内收入出现同比下降，研发投入减少，净亏损额有所收窄，公司整体资产负债状况由正转负，表明在商业化初期仍承受较大的研发与运营压力。 ■ 经营及财务表现...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627214319","title":"Wuhan YZY Biopharma publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2627214319","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627214319?lang=en_us&edition=fundamental","pubTime":"2026-04-16 22:59","pubTimestamp":1776351555,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma published its 2025 annual report, highlighting continued focus on bispecific antibody therapies for oncology-related complications.Lead asset M701 advanced in China, with Phase III malignant ascites trial enrollment completed in July 2025 at 312 patients; follow-up finished in March 2026 with data analysis ongoing.M701 malignant pleural effusion program moved through Phase Ib/II, with Phase II enrollment completed in September 2025 at 92 patients; interim results were presented at ESMO 2025.US expansion for M701 progressed, with FDA IND clearance for pleural effusion disclosed in February 2026.Pipeline execution broadened, with hemophilia candidate Y225 receiving China IND clearance in December 2025; Y101D pancreatic cancer Phase Ib/II study completed with CSR finalized in November 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gener","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL3pw2Py:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163964541","title":"YZYBIO-B Completes 68.01 Million-Share Full-Circulation Conversion, Elevating H-Share Float to 179.48 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1163964541","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163964541?lang=en_us&edition=fundamental","pubTime":"2026-04-08 17:42","pubTimestamp":1775641340,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. (YZYBIO-B) disclosed its Monthly Return on Movements in Securities for March 2026, highlighting the completion of its H-share full-circulation programme and a material...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191739943","title":"YZYBIO-B Lists Additional 68.01 Million H Shares After Converting Domestic and Unlisted Foreign Stock, Enlarging HK-Traded Float by 61%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191739943","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191739943?lang=en_us&edition=fundamental","pubTime":"2026-03-30 17:06","pubTimestamp":1774861563,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. (YZYBIO-B) disclosed that on 30 March 2026 it completed the conversion of 61.14 million domestic shares and 6.87 million unlisted foreign shares into a combined 68.01...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125920309","title":"H-Share Conversion Finalized by YZYBIO-B (02496)","url":"https://stock-news.laohu8.com/highlight/detail?id=1125920309","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125920309?lang=en_us&edition=fundamental","pubTime":"2026-03-30 17:00","pubTimestamp":1774861232,"startTime":"0","endTime":"0","summary":"YZYBIO-B (02496) has announced the completion of the conversion of a total of 68.0103 million non-tradable shares into H-shares on March 30, 2026. The converted H-shares will commence trading on the Stock Exchange of Hong Kong at 9:00 a.m. on March 31, 2026.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623901573","title":"Wuhan YZY Biopharma completes conversion of 68 million unlisted shares into H shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2623901573","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623901573?lang=en_us&edition=fundamental","pubTime":"2026-03-30 16:47","pubTimestamp":1774860450,"startTime":"0","endTime":"0","summary":"Trading of converted H shares is set to begin at 9:00 a.m. on March 31, 2026.H shares rise to 179 million, representing 92.59% of issued share capital.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuhan Yzy Biopharma Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL7rJBrB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623353691","title":"Wuhan YZY Biopharma (SEHK:2496) Loss Deepens In 1H 2025 Challenging Improving Loss Trend Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2623353691","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623353691?lang=en_us&edition=fundamental","pubTime":"2026-03-29 17:10","pubTimestamp":1774775458,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma (SEHK:2496) has just posted its FY 2025 first half numbers, with revenue of C¥44.4 million and a basic EPS loss of C¥0.30 per share, alongside trailing 12 month revenue of C¥149.3 million and a basic EPS loss of C¥0.40. Over recent periods the company has seen revenue move from C¥2.8 million in 1H 2024 to C¥105.0 million in 2H 2024 and C¥44.4 million in 1H 2025. Over the same intervals, EPS shifted from a loss of C¥0.40 to a loss of C¥0.10 and then a loss of C¥0.30 per...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2496/wuhan-yzy-biopharma-shares/news/wuhan-yzy-biopharma-sehk2496-loss-deepens-in-1h-2025-challen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2496/wuhan-yzy-biopharma-shares/news/wuhan-yzy-biopharma-sehk2496-loss-deepens-in-1h-2025-challen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115270281","title":"YZYBIO-B Reports Annual Performance: Net Loss Narrows 13.18% to 84.73 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1115270281","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115270281?lang=en_us&edition=fundamental","pubTime":"2026-03-27 21:36","pubTimestamp":1774618578,"startTime":"0","endTime":"0","summary":"YZYBIO-B (02496) announced its annual results for the period ending December 31, 2025. The group recorded revenue of 66.858 million yuan, representing a decrease of 37.99% compared to the previous...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622242868","title":"Wuhan YZY Biopharma - FY Revenue RMB66.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622242868","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622242868?lang=en_us&edition=fundamental","pubTime":"2026-03-27 21:11","pubTimestamp":1774617086,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F0NJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02496"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622824255","title":"Wuhan Yzy Biopharma FY2025 gross profit drops 87.38% to RMB11 million; revenue falls 37.99% to RMB67 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622824255","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622824255?lang=en_us&edition=fundamental","pubTime":"2026-03-27 21:10","pubTimestamp":1774617037,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma published an annual results announcement for the year ended Dec. 31, 2025, reporting revenue of RMB66.9 million, down 37.99%.License fee income was RMB4.04 million, down 95.12%, as the substantial upfront payment under the CT Tianqing agreement was recognized on signing in 2024, while subsequent income depends on R&D milestones.R&D service income rose to RMB62.82 million, more than doubled, reflecting a full year of service income recognition after the CT Tianqing cooperation took effect in October 2024.Loss for the year was RMB84.73 million, narrowing 13.18%, while R&D expenses fell 52.6% to RMB78.2 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuhan Yzy Biopharma Co. Ltd. published the original content u","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL9mYgN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620442197","title":"Wuhan YZY Biopharma board to review and approve 2025 final results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620442197","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620442197?lang=en_us&edition=fundamental","pubTime":"2026-03-17 16:40","pubTimestamp":1773736846,"startTime":"0","endTime":"0","summary":"YZY Biopharma’s board will meet on March 27, 2026 to consider and approve the group’s final results for the year ended December 31, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuhan Yzy Biopharma Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDLV4rks:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":37,"code":"91000000","status":"200"}]}}